294 related articles for article (PubMed ID: 9769322)
1. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.
Choudhri TF; Hoh BL; Zerwes HG; Prestigiacomo CJ; Kim SC; Connolly ES; Kottirsch G; Pinsky DJ
J Clin Invest; 1998 Oct; 102(7):1301-10. PubMed ID: 9769322
[TBL] [Abstract][Full Text] [Related]
2. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
3. Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab')2 in a model of focal cerebral ischemia in rats.
Yang Y; Li Q; Nakada MT; Yang T; Shuaib A
J Neurosurg; 2001 Apr; 94(4):582-8. PubMed ID: 11302656
[TBL] [Abstract][Full Text] [Related]
4. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
[TBL] [Abstract][Full Text] [Related]
5. FK419, a novel nonpeptide GPIIb/IIIa antagonist, restores microvascular patency and improves outcome in the guinea-pig middle cerebral artery thrombotic occlusion model: comparison with tirofiban.
Moriguchi A; Maeda M; Mihara K; Aoki T; Matsuoka N; Mutoh S
J Cereb Blood Flow Metab; 2005 Jan; 25(1):75-86. PubMed ID: 15678114
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
[TBL] [Abstract][Full Text] [Related]
7. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion.
Zhang ZG; Zhang L; Tsang W; Goussev A; Powers C; Ho KL; Morris D; Smyth SS; Coller BS; Chopp M
Brain Res; 2001 Sep; 912(2):181-94. PubMed ID: 11532435
[TBL] [Abstract][Full Text] [Related]
8. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor.
Ding G; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Ewing JR; Wang Y; Chopp M
J Cereb Blood Flow Metab; 2005 Jan; 25(1):87-97. PubMed ID: 15678115
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
Ching S; Thoma A; Monkman S; Kelton JG
Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
[TBL] [Abstract][Full Text] [Related]
10. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
Lapchak PA; Araujo DM; Song D; Zivin JA
Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
[TBL] [Abstract][Full Text] [Related]
11. Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.
Abumiya T; Fitridge R; Mazur C; Copeland BR; Koziol JA; Tschopp JF; Pierschbacher MD; del Zoppo GJ
Stroke; 2000 Jun; 31(6):1402-09; discussion 1409-10. PubMed ID: 10835463
[TBL] [Abstract][Full Text] [Related]
12. ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Kawano KI; Fujishima K; Ikeda Y; Kondo K; Umemura K
J Cereb Blood Flow Metab; 2000 Jun; 20(6):988-97. PubMed ID: 10894182
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
[TBL] [Abstract][Full Text] [Related]
15. Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke.
Desilles JP; Loyau S; Syvannarath V; Gonzalez-Valcarcel J; Cantier M; Louedec L; Lapergue B; Amarenco P; Ajzenberg N; Jandrot-Perrus M; Michel JB; Ho-Tin-Noe B; Mazighi M
Stroke; 2015 Nov; 46(11):3241-8. PubMed ID: 26443832
[TBL] [Abstract][Full Text] [Related]
16. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study.
Kunichika H; Ben-Yehuda O; Lafitte S; Kunichika N; Peters B; DeMaria AN
J Am Coll Cardiol; 2004 Jan; 43(2):276-83. PubMed ID: 14736449
[TBL] [Abstract][Full Text] [Related]
17. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke.
Connolly ES; Winfree CJ; Springer TA; Naka Y; Liao H; Yan SD; Stern DM; Solomon RA; Gutierrez-Ramos JC; Pinsky DJ
J Clin Invest; 1996 Jan; 97(1):209-16. PubMed ID: 8550836
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Platelet Glycoprotein Receptor Blockade in Aged and Comorbid Mice With Acute Experimental Stroke.
Kraft P; Schuhmann MK; Fluri F; Lorenz K; Zernecke A; Stoll G; Nieswandt B; Kleinschnitz C
Stroke; 2015 Dec; 46(12):3502-6. PubMed ID: 26486866
[TBL] [Abstract][Full Text] [Related]
19. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
[TBL] [Abstract][Full Text] [Related]
20. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
